The global biopharma plastics market is likely to be valued at US$ 5.42 Billion in 2023 and is anticipated to expand at a CAGR of 11.4% until 2033. Owing to the technological advances in hunting equipment the market is likely to propel to US$ 15.95 Billion by 2033.
The expansion and development of the healthcare sector and increased demand for single-use biopharma plastics are likely to drive the growth of the biopharma plastics market in the forecast period.
| Report Attribute | Details |
|---|---|
| Expected Market Value (2023) | US$ 5.42 Billion |
| Projected Forecast Value (2033) | US$ 15.95 Billion |
| Global Growth Rate (2023 to 2033) | 11.4% CAGR |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The biopharma plastics market is expected to gain market growth in the forecast period of 2023 to 2033. Latest market analysis by FMI the market is to grow at a CAGR of 11.4% in the above-mentioned forecast period.
The COVID-19 pandemic has affected positively the Biopharma Plastics Market. During this pandemic, there was an immense requirement from the hospitals for biopharma plastic-based products such as syringes, gloves, and masks resulting in the surging demand for biopharma plastics polymers
The usage of biopharma plastics in various end-use industries is expanding as technology is developing all the time. Manufacturers are interested in investing in the research and development of biopharma plastics to boost the downstream usability of these materials in sectors such as healthcare, agriculture, packaging, and others.
Technological Advancements in Healthcare to boost the biopharma plastics market growth
Biopharma plastics are being utilized for providing higher stability to several applications including depth filters, syringes, and containers. Increased preference for use of high-grade polymers material in the construction of single-use biopharma plastics has fuelled the market growth.
Different types of polymer have several applications including depth filters, syringes, and containers. The market offers opportunities for the usage of a variety of polymer types such as PP, PE, PET, PTFE, and ABS as these polymer types are used for manufacturing biopharma plastic components including personal equipment (PPE), face masks, gloves, and gowns.
Increasing health concerns and growth in healthcare expenditure are expected to drive the market for biopharma plastics along with polymers. Moreover, the presence of large-scale PP molding facilities and the manufacturing sector is projected to propel the market growth over the forecast period. Industry leaders are investing heavily in Research and Development to provide biopharmaceutical products that suit every aspect of consumer needs, which is driving the biopharma plastics market.
Increasing Investments in Single-Use Products to drive the growth of the Global Biopharma Plastics Market
The increasing investments in single-use products for pharmaceutical processing are expected to fuel the growth of global biopharma plastics over the forecast period.
The global biopharma plastics market is being driven by prominent factors such as a rise in the incidence of chronic illnesses such as cancer and diabetes, as well as the increasing global adoption of single-use plastics.
Rapid advancements by prominent players toward constant innovations backed by technologies in the field of biopharmaceuticals act as one of the major factors strongly supporting the global growth of the biopharma plastics market.
Principal Consultant
Although the biopharma plastics market has numerous end-uses, there are some obstacles that likely pose a challenge to market growth during the forecast period.
Patented production processes and high raw material costs have made it difficult for new companies to enter the biopharma plastics industry. The widespread accessibility of alternatives and strict regulatory environment is also hampering the biopharma plastics market growth.
Increased advancement in medical technology to propel the market growth
North America is expected to register a CAGR of 11.6% in the biopharma plastics market, with the USA market for biopharma plastics contributing higher revenue, due to an increase in the number of healthcare facilities and advancements in medical technology.
The North American biopharma plastics market growth will be further fuelled by the increasing demand for these plastics in pharmaceutical packaging applications, itself due to the booming pharmaceutical industry in Canada. Additionally, many medical component and device manufacturers in the USA are adopting biopharma plastics in their products. Another significant element propelling the market in the nations is the existence of leading manufacturers and suppliers of medical-grade plastics.
The presence of key manufacturers of biopharma plastics such as Celanese Corporation, Eastman Chemical Co., and DuPont can be regarded as one of the leading factors driving the market in the country. Additionally, strong purchasing power coupled with high technological acceptance is a major factor for market growth in the region.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The Europe biopharma plastics market is expected to rise at a CAGR of 11.4% from 2023 to 2033. Europe is the second-largest shareholder in the market, mainly due to the growing political support and favorable reimbursement regulations for medical devices.
Additionally, updates to the region's medical device directives will improve the effectiveness, innovation potential, and safety of medical products. As a result, the demand for better medical devices would rise, which will likely have a favorable impact on the market.
Asia Pacific is likely to dominate the biopharma plastics market owing to rapidly growing industries in emerging economies such as India, China, and South Korea. Asia Pacific region has high demand and high manufacturing capacity due to the large population.
Asia-Pacific is expected to deliver impressive outcomes in the global biopharma plastics market. A large amount of investment, significant government meddling in the healthcare sector, and significant development in the developing economy all contribute to increased demand for biopharma plastics.
Furthermore, advancements in healthcare infrastructure, rising government spending on healthcare policies, and the presence of important members in Asia Pacific all contribute to the growth of the global biopharma plastics market.
| United Kingdom | 11.4% |
|---|---|
| India | 11.2% |
| South Korea | 11% |
| China | 11.3% |
| USA | 11.6 % |
Polyvinyl chloride (PVC) dominated the market
Among all the polymer types polyvinyl chloride segment dominates the global market. Polyvinyl chloride accounted for more than 21.5% share of the overall revenue in 2023.
Polyvinyl chloride has the ability to undergo many processes without breaking or cracking, which accounts for its multiple uses in the market. It is extremely flexible, resistant, and can easily withstand high temperatures, making it suitable for the production of syringes, disposable connectors, depth filters, and other applications of biopharma plastics.
The presence of large-scale PP molding facilities and the manufacturing sector is projected to propel the market growth over the forecast period. Other polymer types such as polyethylene and polytetrafluoroethylene are mainly used in various applications owing to their properties such as gloss, durability, and detergent resistance all these factors are likely to boost market growth over the forecast period.
Syringes Segment remains dominant among other types
Based on application, the global biopharma plastics market can be categorized into Protective wear, Container, Bioreactor Bags, Syringes, Depth Filter, Disposable Medical Connectors, and Others. The syringes segment accounts for a market share of 20.2% through 2023. The Increasing demand for prefilled syringes owing to their usage convenience, low costs, minimal microbial contamination, low injection errors, and dilution errors is expected to boost the growth of the market.
Syringes are among the most popular healthcare products used by medical professionals to inject liquids and semi-solid compositions into the bodies of humans and animals. They are also used for withdrawing fluids as well for cleaning wounds or body cavities. The increased need for technically advanced healthcare and growing production of large molecules, and the rising expenditure for the development of advanced healthcare facilities are fueling the growth. The ease of usage and convenience offered by disposable biopharma plastic syringes boost the segment's growth.
How do New Entrants Contribute to the Biopharma Plastics Market?
With technological innovations happening at a rapid pace, and companies looking for ways to increase customer engagement, start-ups are taking all possible steps to establish a name for themselves in the biopharma plastics market.
Some of the start-ups in the biopharma plastics market include-
BASF SE, LyondellBasell Industries Holdings B.V., SABIC, LG chem, Toray Industries, Inc., Solvay, Dow, Inc., DuPont de Nemours, Inc., Saint-Gobain Performance Plastics, Tekni-Plex are some of the key players in the biopharma plastics industry.
The manufacturers are involved in the production of biopharma plastics in a larger capacity. Research and innovation are also conducted to launch innovative plastics for biopharmaceutical products. Also, some of the key players are acquiring small pharmaceutical companies to increase their production capacity.
| Report Attribute | Details |
|---|---|
| Growth Rate | CAGR of 11.4% from 2023 to 2033 |
| Expected Market Value (2023) | US$ 5.42 Billion |
| Projected Forecast Value (2033) | US$ 15.95 Billion |
| Base Year for Estimation | 2022 |
| Historical Data | 2018 to 2022 |
| Forecast Period | 2023 to 2033 |
| Quantitative Units | Revenue in USD Million & CAGR from 2023 to 2033 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends & Pricing Analysis |
| Segments Covered |
|
| Regions Covered |
|
| Key Countries Profiled |
|
| Key Companies Profiled |
|
| Customization | Available Upon Request |
The global biopharma plastics market is likely to reach a valuation of US$ 5.42 Billion by the end of 2023
BASF SE, LyondellBasell Industries Holdings B.V., SABIC, LG chem, Toray Industries, Inc., Solvay, and Dow, Inc. are some of the key players in the global biopharma plastics market
Sales of the biopharma plastics market are likely to expand at 11.4% CAGR through 2033.
The U.S., Canada, Japan, China, & Germany are expected to drive most of the demand for the biopharma plastics market.
By the end of 2033, the global market for biopharma plastics market is predicted to reach a valuation of US$ 15.95 Billion
1. Executive Summary | Biopharma Plastics Market 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Product Life Cycle Analysis 3.5. Supply Chain Analysis 3.5.1. Supply Side Participants and their Roles 3.5.1.1. Producers 3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers) 3.5.1.3. Wholesalers and Distributors 3.5.2. Value Added and Value Created at Node in the Supply Chain 3.5.3. List of Raw Material Suppliers 3.5.4. List of Existing and Potential Buyers 3.6. Investment Feasibility Matrix 3.7. Value Chain Analysis 3.7.1. Profit Margin Analysis 3.7.2. Wholesalers and Distributors 3.7.3. Retailers 3.8. PESTLE and Porter’s Analysis 3.9. Regulatory Landscape 3.9.1. By Key Regions 3.9.2. By Key Countries 3.10. Regional Parent Market Outlook 3.11. Production and Consumption Statistics 3.12. Import and Export Statistics 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 4.1. Historical Market Size Value (US$ Million) & Volume (Tons) Analysis, 2018 to 2022 4.2. Current and Future Market Size Value (US$ Million) & Volume (Tons) Projections, 2023 to 2033 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Polymer Type 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) & Volume (Tons) Analysis By Polymer Type, 2018 to 2022 5.3. Current and Future Market Size Value (US$ Million) & Volume (Tons) Analysis and Forecast By Polymer Type, 2023 to 2033 5.3.1. Polyethylene - PE 5.3.2. Polypropylene - PP 5.3.3. Acrylonitrile Butadiene Styrene - ABS 5.3.4. Polyethylene Terephthalate - PET 5.3.5. Polyvinyl Chloride - PVC 5.3.6. Polytetrafluoroethylene - PTFE 5.3.7. Other 5.4. Y-o-Y Growth Trend Analysis By Polymer Type, 2018 to 2022 5.5. Absolute $ Opportunity Analysis By Polymer Type, 2023 to 2033 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) & Volume (Tons) Analysis By Application, 2018 to 2022 6.3. Current and Future Market Size Value (US$ Million) & Volume (Tons) Analysis and Forecast By Application, 2023 to 2033 6.3.1. Protective Wear 6.3.2. Containers 6.3.3. Bioreactor Bags 6.3.4. Syringes 6.3.5. Depth Filters 6.3.6. Disposable Medical Connectors 6.3.7. Others 6.4. Y-o-Y Growth Trend Analysis By Application, 2018 to 2022 6.5. Absolute $ Opportunity Analysis By Application, 2023 to 2033 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 7.1. Introduction 7.2. Historical Market Size Value (US$ Million) & Volume (Tons) Analysis By Region, 2018 to 2022 7.3. Current Market Size Value (US$ Million) & Volume (Tons) Analysis and Forecast By Region, 2023 to 2033 7.3.1. North America 7.3.2. Latin America 7.3.3. Europe 7.3.4. Asia Pacific 7.3.5. Middle East and Africa(MEA) 7.4. Market Attractiveness Analysis By Region 8. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 8.1. Historical Market Size Value (US$ Million) & Volume (Tons) Trend Analysis By Market Taxonomy, 2018 to 2022 8.2. Market Size Value (US$ Million) & Volume (Tons) Forecast By Market Taxonomy, 2023 to 2033 8.2.1. By Country 8.2.1.1. USA 8.2.1.2. Canada 8.2.2. By Polymer Type 8.2.3. By Application 8.3. Market Attractiveness Analysis 8.3.1. By Country 8.3.2. By Polymer Type 8.3.3. By Application 8.4. Key Takeaways 9. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 9.1. Historical Market Size Value (US$ Million) & Volume (Tons) Trend Analysis By Market Taxonomy, 2018 to 2022 9.2. Market Size Value (US$ Million) & Volume (Tons) Forecast By Market Taxonomy, 2023 to 2033 9.2.1. By Country 9.2.1.1. Brazil 9.2.1.2. Mexico 9.2.1.3. Rest of Latin America 9.2.2. By Polymer Type 9.2.3. By Application 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Polymer Type 9.3.3. By Application 9.4. Key Takeaways 10. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 10.1. Historical Market Size Value (US$ Million) & Volume (Tons) Trend Analysis By Market Taxonomy, 2018 to 2022 10.2. Market Size Value (US$ Million) & Volume (Tons) Forecast By Market Taxonomy, 2023 to 2033 10.2.1. By Country 10.2.1.1. Germany 10.2.1.2. United Kingdom 10.2.1.3. France 10.2.1.4. Spain 10.2.1.5. Italy 10.2.1.6. Rest of Europe 10.2.2. By Polymer Type 10.2.3. By Application 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Polymer Type 10.3.3. By Application 10.4. Key Takeaways 11. Asia Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11.1. Historical Market Size Value (US$ Million) & Volume (Tons) Trend Analysis By Market Taxonomy, 2018 to 2022 11.2. Market Size Value (US$ Million) & Volume (Tons) Forecast By Market Taxonomy, 2023 to 2033 11.2.1. By Country 11.2.1.1. China 11.2.1.2. Japan 11.2.1.3. South Korea 11.2.1.4. Singapore 11.2.1.5. Thailand 11.2.1.6. Indonesia 11.2.1.7. Australia 11.2.1.8. New Zealand 11.2.1.9. Rest of Asia Pacific 11.2.2. By Polymer Type 11.2.3. By Application 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Polymer Type 11.3.3. By Application 11.4. Key Takeaways 12. MEA Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12.1. Historical Market Size Value (US$ Million) & Volume (Tons) Trend Analysis By Market Taxonomy, 2018 to 2022 12.2. Market Size Value (US$ Million) & Volume (Tons) Forecast By Market Taxonomy, 2023 to 2033 12.2.1. By Country 12.2.1.1. GCC Countries 12.2.1.2. South Africa 12.2.1.3. Israel 12.2.1.4. Rest of Middle East and Africa(MEA) 12.2.2. By Polymer Type 12.2.3. By Application 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Polymer Type 12.3.3. By Application 12.4. Key Takeaways 13. Key Countries Market Analysis 13.1. USA 13.1.1. Pricing Analysis 13.1.2. Market Share Analysis, 2022 13.1.2.1. By Polymer Type 13.1.2.2. By Application 13.2. Canada 13.2.1. Pricing Analysis 13.2.2. Market Share Analysis, 2022 13.2.2.1. By Polymer Type 13.2.2.2. By Application 13.3. Brazil 13.3.1. Pricing Analysis 13.3.2. Market Share Analysis, 2022 13.3.2.1. By Polymer Type 13.3.2.2. By Application 13.4. Mexico 13.4.1. Pricing Analysis 13.4.2. Market Share Analysis, 2022 13.4.2.1. By Polymer Type 13.4.2.2. By Application 13.5. Germany 13.5.1. Pricing Analysis 13.5.2. Market Share Analysis, 2022 13.5.2.1. By Polymer Type 13.5.2.2. By Application 13.6. United Kingdom 13.6.1. Pricing Analysis 13.6.2. Market Share Analysis, 2022 13.6.2.1. By Polymer Type 13.6.2.2. By Application 13.7. France 13.7.1. Pricing Analysis 13.7.2. Market Share Analysis, 2022 13.7.2.1. By Polymer Type 13.7.2.2. By Application 13.8. Spain 13.8.1. Pricing Analysis 13.8.2. Market Share Analysis, 2022 13.8.2.1. By Polymer Type 13.8.2.2. By Application 13.9. Italy 13.9.1. Pricing Analysis 13.9.2. Market Share Analysis, 2022 13.9.2.1. By Polymer Type 13.9.2.2. By Application 13.10. China 13.10.1. Pricing Analysis 13.10.2. Market Share Analysis, 2022 13.10.2.1. By Polymer Type 13.10.2.2. By Application 13.11. Japan 13.11.1. Pricing Analysis 13.11.2. Market Share Analysis, 2022 13.11.2.1. By Polymer Type 13.11.2.2. By Application 13.12. South Korea 13.12.1. Pricing Analysis 13.12.2. Market Share Analysis, 2022 13.12.2.1. By Polymer Type 13.12.2.2. By Application 13.13. Singapore 13.13.1. Pricing Analysis 13.13.2. Market Share Analysis, 2022 13.13.2.1. By Polymer Type 13.13.2.2. By Application 13.14. Thailand 13.14.1. Pricing Analysis 13.14.2. Market Share Analysis, 2022 13.14.2.1. By Polymer Type 13.14.2.2. By Application 13.15. Indonesia 13.15.1. Pricing Analysis 13.15.2. Market Share Analysis, 2022 13.15.2.1. By Polymer Type 13.15.2.2. By Application 13.16. Australia 13.16.1. Pricing Analysis 13.16.2. Market Share Analysis, 2022 13.16.2.1. By Polymer Type 13.16.2.2. By Application 13.17. New Zealand 13.17.1. Pricing Analysis 13.17.2. Market Share Analysis, 2022 13.17.2.1. By Polymer Type 13.17.2.2. By Application 13.18. GCC Countries 13.18.1. Pricing Analysis 13.18.2. Market Share Analysis, 2022 13.18.2.1. By Polymer Type 13.18.2.2. By Application 13.19. South Africa 13.19.1. Pricing Analysis 13.19.2. Market Share Analysis, 2022 13.19.2.1. By Polymer Type 13.19.2.2. By Application 13.20. Israel 13.20.1. Pricing Analysis 13.20.2. Market Share Analysis, 2022 13.20.2.1. By Polymer Type 13.20.2.2. By Application 14. Market Structure Analysis 14.1. Competition Dashboard 14.2. Competition Benchmarking 14.3. Market Share Analysis of Top Players 14.3.1. By Regional 14.3.2. By Polymer Type 14.3.3. By Application 15. Competition Analysis 15.1. Competition Deep Dive 15.1.1. BASF SE 15.1.1.1. Overview 15.1.1.2. Product Portfolio 15.1.1.3. Profitability by Market Segments 15.1.1.4. Sales Footprint 15.1.1.5. Strategy Overview 15.1.1.5.1. Marketing Strategy 15.1.1.5.2. Product Strategy 15.1.1.5.3. Channel Strategy 15.1.2. LyondellBasell Industries Holdings B.V. 15.1.2.1. Overview 15.1.2.2. Product Portfolio 15.1.2.3. Profitability by Market Segments 15.1.2.4. Sales Footprint 15.1.2.5. Strategy Overview 15.1.2.5.1. Marketing Strategy 15.1.2.5.2. Product Strategy 15.1.2.5.3. Channel Strategy 15.1.3. SABIC 15.1.3.1. Overview 15.1.3.2. Product Portfolio 15.1.3.3. Profitability by Market Segments 15.1.3.4. Sales Footprint 15.1.3.5. Strategy Overview 15.1.3.5.1. Marketing Strategy 15.1.3.5.2. Product Strategy 15.1.3.5.3. Channel Strategy 15.1.4. LG Chem 15.1.4.1. Overview 15.1.4.2. Product Portfolio 15.1.4.3. Profitability by Market Segments 15.1.4.4. Sales Footprint 15.1.4.5. Strategy Overview 15.1.4.5.1. Marketing Strategy 15.1.4.5.2. Product Strategy 15.1.4.5.3. Channel Strategy 15.1.5. Toray Industries, Inc. 15.1.5.1. Overview 15.1.5.2. Product Portfolio 15.1.5.3. Profitability by Market Segments 15.1.5.4. Sales Footprint 15.1.5.5. Strategy Overview 15.1.5.5.1. Marketing Strategy 15.1.5.5.2. Product Strategy 15.1.5.5.3. Channel Strategy 15.1.6. Solvay 15.1.6.1. Overview 15.1.6.2. Product Portfolio 15.1.6.3. Profitability by Market Segments 15.1.6.4. Sales Footprint 15.1.6.5. Strategy Overview 15.1.6.5.1. Marketing Strategy 15.1.6.5.2. Product Strategy 15.1.6.5.3. Channel Strategy 15.1.7. Dow, Inc. 15.1.7.1. Overview 15.1.7.2. Product Portfolio 15.1.7.3. Profitability by Market Segments 15.1.7.4. Sales Footprint 15.1.7.5. Strategy Overview 15.1.7.5.1. Marketing Strategy 15.1.7.5.2. Product Strategy 15.1.7.5.3. Channel Strategy 15.1.8. DuPont de Nemours, Inc. 15.1.8.1. Overview 15.1.8.2. Product Portfolio 15.1.8.3. Profitability by Market Segments 15.1.8.4. Sales Footprint 15.1.8.5. Strategy Overview 15.1.8.5.1. Marketing Strategy 15.1.8.5.2. Product Strategy 15.1.8.5.3. Channel Strategy 15.1.9. Saint-Gobain Performance Plastics 15.1.9.1. Overview 15.1.9.2. Product Portfolio 15.1.9.3. Profitability by Market Segments 15.1.9.4. Sales Footprint 15.1.9.5. Strategy Overview 15.1.9.5.1. Marketing Strategy 15.1.9.5.2. Product Strategy 15.1.9.5.3. Channel Strategy 15.1.10. Tekni-Plex 15.1.10.1. Overview 15.1.10.2. Product Portfolio 15.1.10.3. Profitability by Market Segments 15.1.10.4. Sales Footprint 15.1.10.5. Strategy Overview 15.1.10.5.1. Marketing Strategy 15.1.10.5.2. Product Strategy 15.1.10.5.3. Channel Strategy 15.1.11. Chevron Phillips Chemical Co., LLC 15.1.11.1. Overview 15.1.11.2. Product Portfolio 15.1.11.3. Profitability by Market Segments 15.1.11.4. Sales Footprint 15.1.11.5. Strategy Overview 15.1.11.5.1. Marketing Strategy 15.1.11.5.2. Product Strategy 15.1.11.5.3. Channel Strategy 15.1.12. Exxon Mobil Corporation 15.1.12.1. Overview 15.1.12.2. Product Portfolio 15.1.12.3. Profitability by Market Segments 15.1.12.4. Sales Footprint 15.1.12.5. Strategy Overview 15.1.12.5.1. Marketing Strategy 15.1.12.5.2. Product Strategy 15.1.12.5.3. Channel Strategy 15.1.13. Formosa Plastics Corporation 15.1.13.1. Overview 15.1.13.2. Product Portfolio 15.1.13.3. Profitability by Market Segments 15.1.13.4. Sales Footprint 15.1.13.5. Strategy Overview 15.1.13.5.1. Marketing Strategy 15.1.13.5.2. Product Strategy 15.1.13.5.3. Channel Strategy 15.1.14. Covestro AG 15.1.14.1. Overview 15.1.14.2. Product Portfolio 15.1.14.3. Profitability by Market Segments 15.1.14.4. Sales Footprint 15.1.14.5. Strategy Overview 15.1.14.5.1. Marketing Strategy 15.1.14.5.2. Product Strategy 15.1.14.5.3. Channel Strategy 15.1.15. TEIJIN LIMITED 15.1.15.1. Overview 15.1.15.2. Product Portfolio 15.1.15.3. Profitability by Market Segments 15.1.15.4. Sales Footprint 15.1.15.5. Strategy Overview 15.1.15.5.1. Marketing Strategy 15.1.15.5.2. Product Strategy 15.1.15.5.3. Channel Strategy 15.1.16. Mitsui & Co. Plastics Ltd. 15.1.16.1. Overview 15.1.16.2. Product Portfolio 15.1.16.3. Profitability by Market Segments 15.1.16.4. Sales Footprint 15.1.16.5. Strategy Overview 15.1.16.5.1. Marketing Strategy 15.1.16.5.2. Product Strategy 15.1.16.5.3. Channel Strategy 15.1.17. INEOS Group 15.1.17.1. Overview 15.1.17.2. Product Portfolio 15.1.17.3. Profitability by Market Segments 15.1.17.4. Sales Footprint 15.1.17.5. Strategy Overview 15.1.17.5.1. Marketing Strategy 15.1.17.5.2. Product Strategy 15.1.17.5.3. Channel Strategy 15.1.18. CHIMEI 15.1.18.1. Overview 15.1.18.2. Product Portfolio 15.1.18.3. Profitability by Market Segments 15.1.18.4. Sales Footprint 15.1.18.5. Strategy Overview 15.1.18.5.1. Marketing Strategy 15.1.18.5.2. Product Strategy 15.1.18.5.3. Channel Strategy 16. Assumptions & Acronyms Used 17. Research Methodology
Explore Chemicals & Materials Insights
View Reports
Biopharma Plastics Market
